Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Program Expansion of a Day Hospital Dedicated to Manage Sickle Cell Pain

Jin Han, PharmD, PhD, Laura Kavoliunaite, APN, Santosh L. Saraf, MD, Shivi Jain, MD, Johara Hassan, MD, Lewis L Hsu, MD PhD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Michel Gowhari, DO

Blood (2017) 130 (Supplement 1): 4664.

https://doi.org/10.1182/blood.V130.Suppl_1.4664.4664

Published: 2017

Journal Articles

Phase 1 Evaluation of Oral Tetrahydrouridine-Decitabine As Non-Cytotoxic Epigenetic Disease Modification for Sickle Cell Disease

Robert E Molokie, MD, Donald Lavelle, PhD, Michel Gowhari, DO, Michael Pacini, PharmD, Lani Krauz, Johara Hassan, MD, Vinzon Ibanez, Maria A Ruiz, Daisy Pacelli, Sherry Fada, Mitch A. Phelps, PhD, Santosh L. Saraf, MD, Lewis L. Hsu, MD PhD, Victor R. Gordeuk, MD, Joseph DeSimone, PhD, Yogenthiran Saunthararajah, MD

Blood (2016) 128 (22): 124.

https://doi.org/10.1182/blood.V128.22.124.124

Published: 2016

Journal Articles

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Kidney Function in Patients with Sickle Cell Disease

Jun Choi, MD, Naina Singh, MD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Johara Hassan, MD, Shivi Jain, MD, Robert E Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2016) 128 (22): 3666.

https://doi.org/10.1182/blood.V128.22.3666.3666

Published: 2016

Journal Articles

Utility of the Revised Cardiac Index Score for Predicting Post-Surgical Outcome in Hb SC or SBeta + -Thalassemia Sickle Cell Disease

Hamid Wardak, Ari Rosenberg, Vladimir Selounski, Michel Gowhari, DO, Robert E. Molokie, MD, Johara Hassan, MD, Jin Han, PharmD, PhD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2015) 126 (23): 3413.

https://doi.org/10.1182/blood.V126.23.3413.3413

Published: 2015

Journal Articles

Chronic Opioid Use Pattern in Adult Patients with Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Xu Zhang, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Johara Hassan, MD, Chaher Alhandalous, MD, Jewel Younge, MA, Taimur Abbasi, MD, Roberto F. Machado, MD, Victor R. Gordeuk, MD

Blood (2015) 126 (23): 3400.

https://doi.org/10.1182/blood.V126.23.3400.3400

Published: 2015

Journal Articles

Combination with Thu to Address Pharmacologic Limitations of Decitabine, Interim PK/PD from a Phase 1/2 Clinical Trial of Oral Thu-Decitabine in Sickle Cell Disease

Donald Lavelle, PhD, Michel Gowhari, DO, Michael Pacini, PharmD, Lani Krauz, RN, Johara Hassan, MD, Vinzon Ibanez, Maria A. Ruiz, MSc, Daisy Pacelli, BSc, Chaher Alhandalous, MD, Mitch A. Phelps, PhD, Kathleen Fenner, BS,MS, Reda Z. Mahfouz, MDPhD, John Barnard, Lewis L. Hsu, MD PhD, Victor R. Gordeuk, MD, Joseph DeSimone, PhD, Yogen Saunthararajah, MD, Robert E. Molokie, MD

Blood (2014) 124 (21): 90.

https://doi.org/10.1182/blood.V124.21.90.90

Published: 2014

Journal Articles

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Santosh L. Saraf, MD, Annie L. Oh, MD, Dolores Mahmud, PhD, Pritesh R. Patel, MB, ChB, Karen Sweiss, PharmD, Matthew Koshy, MD, Sally Campbell-Lee, MD, Michel Gowhari, DO, Johara Hassan, MD, David Peace, MD, John G. Quigley, MD, Irum Khan, MBBS, Robert E. Molokie, MD, Lewis L. Hsu, MD PhD, Nadim Mahmud, MD PhD, Dennis J Levinson, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2014) 124 (21): 2703.

https://doi.org/10.1182/blood.V124.21.2703.2703

Published: 2014

Journal Articles

Age As an Independent Clinical Predictor for Vitamin D Deficiency in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Taimur Abbasi, MD, Xu Zhang, PhD, Robert E. Molokie, MD, Johara Hassan, MD, Michel Gowhari, DO, Chaher Alhandalous, MD, Roberto F. Machado, MD, Victor R. Gordeuk, MD

Blood (2014) 124 (21): 1385.

https://doi.org/10.1182/blood.V124.21.1385.1385

Published: 2014

Journal Articles

Hemoglobinuria Is a Risk Factor For Kidney Disease Progression In Sickle Cell Anemia

Santosh L. Saraf, MD, Xu Zhang, PhD, Tamir Kanias, PhD, James P. Lash, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Johara Hassan, MD, Mark T. Gladwin, MD, Victor R. Gordeuk, MD

Blood (2013) 122 (21): 996.

https://doi.org/10.1182/blood.V122.21.996.996

Published: 2013

Journal Articles

Hyperfiltration Is a Risk Factor For The Development Of Microalbuminuria In Sickle Cell Anemia

Benjamin Vazquez, Santosh L. Saraf, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Johara Hassan, MD, James P. Lash, MD, Victor R. Gordeuk, MD

Blood (2013) 122 (21): 1003.

https://doi.org/10.1182/blood.V122.21.1003.1003

Published: 2013

Journal Articles

Clinical Efficacy and Safety of Erythroid Stimulating Agents in Sickle Cell Disease

Santosh Saraf, MD, Robert Molokie, MD, Michel Gowhari, DO, Johara Hassan, MD, Victor R. Gordeuk, MD

Blood (2012) 120 (21): 3218.

https://doi.org/10.1182/blood.V120.21.3218.3218

Published: 2012

Journal Articles

Pain Medication: Time to First Dose in Sickle Cell Acute Care in Two Settings of a Large Urban Hospital

Bonnye Johnson, MS, RN, Dawn Lei, BS, Nicholas F Furtado, MD, Saman K. Hashmi, MD, Robert Molokie, MD, Joseph DeSimone, PhD, Johara Hassan, MD, Michel Gowhari, DO, Tara Gordon, RN, Darcel Dowell, RN, Glenda Pendarvis, RN, Heather Prendergast, MD, Victor R. Gordeuk, MD, Lewis L. Hsu, MD, PhD

Blood (2012) 120 (21): 4693.

https://doi.org/10.1182/blood.V120.21.4693.4693

Published: 2012

Journal Articles

Clinical and Laboratory Predictors for Renal Damage in Sickle Cell Disease

Santosh L Saraf, MD, Robert Molokie, MD, Johara Hassan, MD, Michel Gowhari, DO, James Lash, MD, Victor R. Gordeuk, MD

Blood (2012) 120 (21): 3252.

https://doi.org/10.1182/blood.V120.21.3252.3252

Published: 2012

NARROW

Program Expansion of a Day Hospital Dedicated to Manage Sickle Cell Pain

Phase 1 Evaluation of Oral Tetrahydrouridine-Decitabine As Non-Cytotoxic Epigenetic Disease Modification for Sickle Cell Disease

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Kidney Function in Patients with Sickle Cell Disease

Utility of the Revised Cardiac Index Score for Predicting Post-Surgical Outcome in Hb SC or SBeta + -Thalassemia Sickle Cell Disease

Chronic Opioid Use Pattern in Adult Patients with Sickle Cell Disease

Combination with Thu to Address Pharmacologic Limitations of Decitabine, Interim PK/PD from a Phase 1/2 Clinical Trial of Oral Thu-Decitabine in Sickle Cell Disease

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Age As an Independent Clinical Predictor for Vitamin D Deficiency in Sickle Cell Disease

Hemoglobinuria Is a Risk Factor For Kidney Disease Progression In Sickle Cell Anemia

Hyperfiltration Is a Risk Factor For The Development Of Microalbuminuria In Sickle Cell Anemia

Clinical Efficacy and Safety of Erythroid Stimulating Agents in Sickle Cell Disease

Pain Medication: Time to First Dose in Sickle Cell Acute Care in Two Settings of a Large Urban Hospital

Clinical and Laboratory Predictors for Renal Damage in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only